Based on the Real-World Results From Australia, Immunotherapy Is Not a Good Option for Patients With Mesothelioma

J Thorac Oncol. 2024 Apr;19(4):541-546. doi: 10.1016/j.jtho.2024.01.016.

¹ Thoracic Oncology Research Group, Trinity St James's Cancer Institute, St James's Hospital, Dublin, Ireland.
² Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel.
³ Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy; Center of Biotechnology, College of Science and Technology, Temple University, Sbarro Health Research Organization, Philadelphia, Pennsylvania. Electronic address: luciano.mutti@univaq.it.

No abstract available

Publication types